Literature DB >> 21435335

Blood-arachnoid barrier disruption in experimental rat meningitis detected using gadolinium-enhancement ratio imaging.

Hiroyuki Ichikawa1, Kouichi Itoh.   

Abstract

Disruption of the central nervous system (CNS) barriers is one of the major pathophysiological consequences of bacterial meningitis. The increase in the permeability of the CNS barriers caused by the disruption is thought to contribute to the development of adverse neurological outcomes. We have established a method by which the CNS barrier permeability can be demonstrated by the gadolinium-enhancement ratio (GER) calculated from the T₁ weighted image (T₁WI) which is based on gadolinium-enhanced magnetic resonance imaging (GdEMRI). The present study examined the disruption of CNS barriers such as blood-brain barrier (BBB), blood-cerebrospinal fluid barrier (BCSFB) and blood-arachnoid barrier (BAB) in rats with meningitis induced by lipopolysaccharide (LPS)- or interleukin (IL)-1β. Four hours after intracisternal injection of LPS or IL-1β, severe disruption of the BAB, but not the BBB or BCSFB, was observed. This suggests that the BAB, rather than the BBB or BCSFB, plays a key role in the influx of blood-borne cells and substances during meningitis. The BAB is therefore more vulnerable to disruption than the BBB or BCSFB during meningitis in rats. In addition, GdEMRI with GER imaging analysis appears to be useful in spatio-temporal studies on the function of the CNS barriers under various physiological and pathological conditions.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21435335     DOI: 10.1016/j.brainres.2011.03.035

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  9 in total

1.  Evaluation of laser speckle contrast imaging as an intrinsic method to monitor blood brain barrier integrity.

Authors:  Suzie Dufour; Yaaseen Atchia; Raanan Gad; Dene Ringuette; Iliya Sigal; Ofer Levi
Journal:  Biomed Opt Express       Date:  2013-08-30       Impact factor: 3.732

2.  Gadolinium- and 5-aminolevulinic acid-induced protoporphyrin IX levels in human gliomas: an ex vivo quantitative study to correlate protoporphyrin IX levels and blood-brain barrier breakdown.

Authors:  Pablo A Valdés; Ziev B Moses; Anthony Kim; Clifford J Belden; Brian C Wilson; Keith D Paulsen; David W Roberts; Brent T Harris
Journal:  J Neuropathol Exp Neurol       Date:  2012-09       Impact factor: 3.685

3.  Prompt meningeal reconstruction mediated by oxygen-sensitive AKAP12 scaffolding protein after central nervous system injury.

Authors:  Jong-Ho Cha; Hee-Jun Wee; Ji Hae Seo; Bum Ju Ahn; Ji-Hyeon Park; Jun-Mo Yang; Sae-Won Lee; Ok-Hee Lee; Hyo-Jong Lee; Irwin H Gelman; Ken Arai; Eng H Lo; Kyu-Won Kim
Journal:  Nat Commun       Date:  2014-09-17       Impact factor: 14.919

4.  Outer brain barriers in rat and human development.

Authors:  Christian B Brøchner; Camilla B Holst; Kjeld Møllgård
Journal:  Front Neurosci       Date:  2015-03-16       Impact factor: 4.677

5.  Optical imaging to map blood-brain barrier leakage.

Authors:  Hayder Jaffer; Isaac M Adjei; Vinod Labhasetwar
Journal:  Sci Rep       Date:  2013-11-01       Impact factor: 4.379

Review 6.  Mechanism of West Nile virus neuroinvasion: a critical appraisal.

Authors:  Willy W Suen; Natalie A Prow; Roy A Hall; Helle Bielefeldt-Ohmann
Journal:  Viruses       Date:  2014-07-18       Impact factor: 5.048

Review 7.  Innate Lymphoid Cells in the Central Nervous System.

Authors:  Shuaiwei Wang; Serge A van de Pavert
Journal:  Front Immunol       Date:  2022-02-03       Impact factor: 7.561

Review 8.  Living on the Edge of the CNS: Meninges Cell Diversity in Health and Disease.

Authors:  Julia Derk; Hannah E Jones; Christina Como; Bradley Pawlikowski; Julie A Siegenthaler
Journal:  Front Cell Neurosci       Date:  2021-07-01       Impact factor: 5.505

Review 9.  Utility of CSF in translational neuroscience.

Authors:  Elizabeth C M de Lange
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-02-12       Impact factor: 2.745

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.